Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Just dreaming...and not that they are in danger of doing something that makes sense in Washington, but what if, out of that $4.5 billion a year for the next ten years, they spend $1 billion and bought out the rights to probuphine. Believe me, Braeburn would sell.

Probuphine could then be sold at cost. $600 for four implants (stated cost in Braeburn's S-1 Registration Statement), plus say $200 for distribution, etc. $800 for six months treatment (cheaper than suboxone).

Braeburn and Titan could split the cash per the license agreement. Titan would get its $165 million in milestones, plus 20% or so of the $835 million remaining (call it $167 million) for a final split of $332 million to TTNP and $668 million to Braeburn.